Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial - Part 2

NCT07227246 is registered in ClinicalTrials.gov with Joseph Broderick, MD as lead sponsor.

NCT NCT07227246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07227246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial - Part 2
Lead sponsor
Joseph Broderick, MD
Phase
Phase 3
Overall status
Recruiting
Start date
May 6, 2025
Completion date
June 30, 2029
Enrollment
350 (estimated)
Sites
89

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage